资源描述：
《张江新药药效评价》由会员上传分享，免费在线阅读，更多相关内容在学术论文-天天文库。
1、Innovation.Collaboration.Commitment.ValueZhangjiangPharmaValleyPharmaceutical&HealthcareSeminarSeriesTime:2:00PM-4:30PMonMay11th,20102010年5月11日，2:00-4:30Venue:LectureHall,3F,No.781CailunRd,ZhangjiangHi-TechPark张江高科技园区蔡伦路781号3楼学术报告厅Sponsor:ShanghaiZhangjiangBiotech&PharmaceuticalBaseDeve
2、lopmentCo.,Ltd.上海张江生物医药基地开发有限公司ShanghaiZhangjiang(Group)Co.,Ltd.SMEDept.上海张江（集团）有限公司孵化器管理中心ShanghaiPudongBioIndustryAssociation上海市浦东新区生物产业行业协会ShanghaiPharmaEngineCo.,Ltd.上海张江药谷公共服务平台有限公司Organizer:ShanghaiChemPartnerCo.,Ltd.上海睿智化学研究有限公司Agenda:2:00pm-2:05pm Shortopenningremark2:05
3、pm-2:50pm Dr.GregVerdine:Druggingthe“Undruggable”2:55pm-3:40pm Dr.YigongShi:StructuralInsightsintoProgrammedCellDeath3:45pm-4:30pm Dr.RobertBooth:InhibitionofCathepsinB–ANovelTherapyforLiverFibrosisSpeaker’sBriefIntro:Dr.GregVerdineDr.GregVerdineistheDirectorofth
4、ePrograminCancerChemicalBiologyattheDana-FarberCancerInstitute,andistheErvingProfessorofChemistryatHarvardUniversity.HeholdsacademicappointmentsatHarvardintheDepartmentofStemCellandRegenerativeBiology(SCRB,primary),ChemistryandChemicalBiology(CCB,voting),andMolecularandCellularBiology(M
5、CB,affiliate).HisDana-Farberresearcheffortaimstodiscoverentirelynewmolecularclassesofdrugstotackleso-called“undruggable”targets,whilehisworkintheHarvardFacultyofArtsandSciencesfocusesonunderstandingfundamentalaspectsofDNAdamagerecognitionandrepair.VerdineisasenioradvisortoThirdRockVentu
6、resandtheTexasPacificGroup,andhasfounded,co-foundedorre-foundedsixbiopharmaceuticalcompanies.InOctober2009,Dr.GregVerdineacceptedtheinvitationandformallyjoinedintheglobalexpertiseInnovation.Collaboration.Commitment.ValuetankofShangPharmaCorperation,astheChairmanofthecompany’sSAB.Dr.Robe
7、rtBoothPriortojoiningTPGBiotechin2006,Dr.BoothwastheChiefScientificOfficeratCeleraGenomics,wherehewasresponsibleforleadingalldiscoveryanddevelopmentactivities.Thisincludedresponsibilityforthetherapeutics,proteomics,informatics,IT,intellectualpropertyandbioinformaticsplatformsin
